• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金纳米颗粒增强立体定向放射外科治疗新生血管性年龄相关性黄斑变性。

Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration.

机构信息

Department of Radiation Oncology, Division of Medical Physics and Biophysics, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.

出版信息

Phys Med Biol. 2012 Oct 21;57(20):6371-80. doi: 10.1088/0031-9155/57/20/6371. Epub 2012 Sep 21.

DOI:10.1088/0031-9155/57/20/6371
PMID:22995994
Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries for people over the age of 50. In this work, the dosimetric feasibility of using gold nanoparticles (AuNP) as radiosensitizers to enhance kilovoltage stereotactic radiosurgery for neovascular AMD is investigated. Microdosimetry calculations at the sub-cellular level were carried out to estimate the radiation dose enhancement to individual nuclei in neovascular AMD endothelial cells (nDEF) due to photon-induced photo-/Auger electrons from x-ray-irradiated AuNP. The nDEF represents the ratio of radiation doses to the endothelial cell nuclei with and without AuNP. The calculations were carried out for a range of feasible AuNP local concentrations using the clinically applicable 100 kVp x-ray beam parameters employed by a commercially available x-ray therapy system. The results revealed nDEF values of 1.30-3.26 for the investigated concentration range of 1-7 mg g(-1), respectively. In comparison, for the same concentration range, nDEF values of 1.32-3.40, 1.31-3.33, 1.29-3.19, 1.28-3.12 were calculated for 80, 90, 110 and 120 kVp x-rays, respectively. Meanwhile, calculations as a function of distance from the AuNP showed that the dose enhancement, for 100 kVp, is markedly confined to the targeted neovascular AMD endothelial cells where AuNP are localized. These findings provide impetus for considering the application of AuNP to enhance therapeutic efficacy during stereotactic radiosurgery for neovascular AMD.

摘要

年龄相关性黄斑变性(AMD)是 50 岁以上发达国家人群失明的主要原因。在这项工作中,研究了使用金纳米颗粒(AuNP)作为增敏剂来增强用于新生血管性 AMD 的千伏立体定向放射外科的剂量学可行性。在亚细胞水平进行微剂量学计算,以估计由于 x 射线照射的 AuNP 产生的光/俄歇电子,在新生血管性 AMD 内皮细胞(nDEF)中的各个核的辐射剂量增强。nDEF 表示有和没有 AuNP 时内皮细胞核的辐射剂量比。使用商业可用的 X 射线治疗系统中使用的临床可行的 100 kVp X 射线束参数,针对可行的 AuNP 局部浓度范围进行了计算。结果表明,在所研究的浓度范围为 1-7 mg g(-1) 时,nDEF 值分别为 1.30-3.26。相比之下,对于相同的浓度范围,分别计算了 80、90、110 和 120 kVp X 射线的 nDEF 值为 1.32-3.40、1.31-3.33、1.29-3.19 和 1.28-3.12。同时,作为距离 AuNP 的函数的计算表明,对于 100 kVp,增强的剂量明显局限于 AuNP 定位的靶向新生血管性 AMD 内皮细胞。这些发现为考虑在立体定向放射外科治疗新生血管性 AMD 期间应用 AuNP 来增强治疗效果提供了动力。

相似文献

1
Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration.金纳米颗粒增强立体定向放射外科治疗新生血管性年龄相关性黄斑变性。
Phys Med Biol. 2012 Oct 21;57(20):6371-80. doi: 10.1088/0031-9155/57/20/6371. Epub 2012 Sep 21.
2
SU-E-T-408: Enhancing Stereotactic Radiosurgery for Neovascular Age-Related Macular Degeneration, Using Gold Nanoparticles.SU-E-T-408:使用金纳米颗粒增强立体定向放射外科治疗新生血管性年龄相关性黄斑变性
Med Phys. 2012 Jun;39(6Part16):3798. doi: 10.1118/1.4735497.
3
Kilovoltage radiosurgery with gold nanoparticles for neovascular age-related macular degeneration (AMD): a Monte Carlo evaluation.用于新生血管性年龄相关性黄斑变性(AMD)的金纳米颗粒千伏级放射外科治疗:蒙特卡洛评估
Phys Med Biol. 2015 Dec 21;60(24):9203-13. doi: 10.1088/0031-9155/60/24/9203. Epub 2015 Nov 18.
4
Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement.应用金纳米颗粒作为近距离放疗中的肿瘤血管破坏剂:内皮细胞剂量增强的评估。
Phys Med Biol. 2010 Nov 7;55(21):6533-48. doi: 10.1088/0031-9155/55/21/013. Epub 2010 Oct 19.
5
Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location.金纳米颗粒增敏放疗的临床意义与光子能量、纳米颗粒大小、浓度和位置有关。
Phys Med Biol. 2011 Aug 7;56(15):4631-47. doi: 10.1088/0031-9155/56/15/001. Epub 2011 Jul 6.
6
Gold nanoparticle-aided brachytherapy with vascular dose painting: estimation of dose enhancement to the tumor endothelial cell nucleus.载金纳米颗粒近距离放疗中的血管剂量描绘:肿瘤内皮细胞核的剂量增强估计。
Med Phys. 2012 Jan;39(1):392-8. doi: 10.1118/1.3671905.
7
Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy.通过兆伏 X 射线和靶向金纳米颗粒实现肿瘤血管内皮细胞的局部剂量增强:外照射放疗的新潜力。
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):270-6. doi: 10.1016/j.ijrobp.2010.10.022. Epub 2010 Dec 14.
8
Anti-VEGF agents for age-related macular degeneration.抗血管内皮生长因子药物治疗年龄相关性黄斑变性。
Expert Opin Ther Pat. 2010 Jan;20(1):103-18. doi: 10.1517/13543770902762885.
9
Targeted radiotherapy enhancement during electronic brachytherapy of accelerated partial breast irradiation (APBI) using controlled release of gold nanoparticles.在加速部分乳腺照射(APBI)的电子近距离放射治疗过程中,利用金纳米颗粒的控释实现靶向放疗增强。
Phys Med. 2015 Dec;31(8):1070-1074. doi: 10.1016/j.ejmp.2015.07.138. Epub 2015 Sep 26.
10
Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration.360度视网膜切除术黄斑转位治疗新生血管性年龄相关性黄斑变性后的视觉功能变化
Ophthalmology. 2004 Sep;111(9):1715-24. doi: 10.1016/j.ophtha.2004.03.022.

引用本文的文献

1
Utilization of Nanoparticles for Treating Age-Related Macular Degeneration.纳米颗粒在治疗年龄相关性黄斑变性中的应用
Pharmaceuticals (Basel). 2025 Jan 25;18(2):162. doi: 10.3390/ph18020162.
2
Nano-Biomaterials for Retinal Regeneration.用于视网膜再生的纳米生物材料。
Nanomaterials (Basel). 2021 Jul 22;11(8):1880. doi: 10.3390/nano11081880.
3
A detailed experimental and Monte Carlo analysis of gold nanoparticle dose enhancement using 6 MV and 18 MV external beam energies in a macroscopic scale.在宏观尺度上,使用 6 MV 和 18 MV 外照射能量对金纳米颗粒剂量增强进行详细的实验和蒙特卡罗分析。
Appl Radiat Isot. 2021 May;171:109638. doi: 10.1016/j.apradiso.2021.109638. Epub 2021 Feb 10.
4
Intravitreal Injection of Liposomes Loaded with a Histone Deacetylase Inhibitor Promotes Retinal Ganglion Cell Survival in a Mouse Model of Optic Nerve Crush.脂质体负载组蛋白去乙酰化酶抑制剂玻璃体内注射促进视神经钳夹损伤小鼠模型中视网膜神经节细胞存活。
Int J Mol Sci. 2020 Dec 6;21(23):9297. doi: 10.3390/ijms21239297.
5
Gold nanoparticles to enhance ophthalmic imaging.用于增强眼科成像的金纳米颗粒。
Biomater Sci. 2021 Jan 21;9(2):367-390. doi: 10.1039/d0bm01063d. Epub 2020 Oct 15.
6
Nanoparticle-aided Radiotherapy for Retinoblastoma and Choroidal Melanoma.纳米颗粒辅助放疗用于视网膜母细胞瘤和脉络膜黑色素瘤
IFMBE Proc. 2015;51:907-910. doi: 10.1007/978-3-319-19387-8_221.
7
A Software App for Radiotherapy with In-situ Dose-painting using high Z nanoparticles.一种使用高Z值纳米颗粒进行原位剂量描绘的放射治疗软件应用程序。
IFMBE Proc. 2015 Jun;51:618-621. doi: 10.1007/978-3-319-19387-8_151.
8
Kilovoltage radiosurgery with gold nanoparticles for neovascular age-related macular degeneration (AMD): a Monte Carlo evaluation.用于新生血管性年龄相关性黄斑变性(AMD)的金纳米颗粒千伏级放射外科治疗:蒙特卡洛评估
Phys Med Biol. 2015 Dec 21;60(24):9203-13. doi: 10.1088/0031-9155/60/24/9203. Epub 2015 Nov 18.
9
Nanoparticles for Radiation Therapy Enhancement: the Key Parameters.用于增强放射治疗的纳米颗粒:关键参数
Theranostics. 2015 Jun 11;5(9):1030-44. doi: 10.7150/thno.11642. eCollection 2015.
10
Targeted radiotherapy with gold nanoparticles: current status and future perspectives.金纳米颗粒靶向放射治疗:现状与未来展望。
Nanomedicine (Lond). 2014 May;9(7):1063-82. doi: 10.2217/nnm.14.55.